SCHEMBL13638573

SCHEMBL13638573

CNc1ccc2c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4cc(Cl)c(Cl)s4)cc3)cc(S)c2c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.43
PTGER3 P43115 15/20 0.36
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PTGER4 P35408 1/20 0.33
PTGER2 P43116 1/20 0.33
PTGIR P43119 1/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA9 Q16790 2/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
FBP1 P09467 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922975 0.92 P2RY12 (0.42) P2RY12PTGER3CA12CA1CA9
SCHEMBL12161536 0.90 P2RY12 (0.43) P2RY12PTGER3CYP3A4CYP2C9CYP2C19
SCHEMBL9922465 0.89 P2RY12 (0.53) P2RY12CA12CA1CA9ALDH1A1
SCHEMBL12161526 0.88 P2RY12 (0.42) P2RY12PTGER3CYP3A4CYP2C9CYP2C19
SCHEMBL14228353 0.88 P2RY12 (0.42) P2RY12PTGER3CYP3A4CYP2C9CYP2C19
SCHEMBL12161535 0.87 GAA (0.44) P2RY12PTGER3KDM4EALDH1A1LMNA
SCHEMBL12161531 0.87 P2RY12 (0.41) P2RY12PTGER3CYP3A4CYP2C9CYP2C19
SCHEMBL12177655 0.87 P2RY12 (0.38) P2RY12CA12CA1CA9FBP1
SCHEMBL12161530 0.87 P2RY12 (0.41) P2RY12PTGER3CYP3A4CYP2C9CYP2C19
SCHEMBL12161546 0.87 ESRRA (0.43) P2RY12PTGER3CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed